Patent · US Active

Compositions and methods for topical application and transdermal delivery of botulinum toxins

US10744078B2 · kind B2 · utility

5Cited by
96References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2018
Grant dateAug 18, 2020
Priority date
Expiry dateSep 24, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24069
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved formulations for transdermal delivery of botulinum toxin are disclosed. The formulations include, for example, botulinum toxin non-covalently associated with a positively charged backbone having branching or efficiency groups. The formulations also include a partitioning agent, oligo-bridge, or polyanion bridge, and may optionally contain a viscosity modifying agent. The formulations are designed for topical application onto the skin of a patient and may be used to treat wrinkles, hyperhidrosis, and other health-related problems. Kits for administration are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.